Metagenomics Sequencing Market Overview:
The global metagenomics sequencing market size was valued at $974.30 million in 2020, and is projected to reach $3,646.53 million by 2028, registering a CAGR of 17.5% from 2021 to 2028.
Metagenomics is the study of genomes collectively in a microbial community. This process involves cloning and analyzing the genomes without culturing the organisms in the community. Metagenomics process has been responsible for substantial advances in microbial ecology, evolution, and diversity; this activity is mainly engaged in many research laboratories now. The global metagenomics sequencing market growth is largely driven by factors such as significant applications of metagenomics in various fields, various initiatives and funding from government & private bodies for large-scale sequencing projects, and decline in cost of sequencing. Increase in advancements regarding DNA sequencing and rise in expansion of metagenomics sequencing applications drive the growth of the global metagenomics sequencing market. Moreover, developing nations offer profitable opportunities for metagenomics sequencing product manufacturers.
The growth of the global metagenomics sequencing market is majorly driven by growth in demand for drug discovery, clinical diagnostics, and increase in prevalence of genetic disorder. In addition, metagenomic technologies enable the study of microbial communities as entire units without entailing the need of cultivating them. As uncultivability and genomic diversity serve as the two major roadblocks in the advancements of environmental and clinical microbiology, metagenomics has gained immense traction among the healthcare professionals and researchers. The advancement in metagenomics sequencing technologies is projected to increase the growth opportunities for the metagenomics sequencing market.
COVID-19 Impact
Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. The COVID-19 pandemic has resulted in nationwide lockdowns, thereby impacting every industry vertical. According to the report of the United Nations Human Rights, the COVID-19 pandemic has threatened all the members of the society. As a result, health care systems are affected, and the effective delivery of medical care and treatment to all patients has become a challenge worldwide. The overall impact of COVID-19 pandemic is likely to remain positive for the metagenomics sequencing market. As, throughout the COVID-19 pandemic, clinical diagnostics and testing is a critical component of the response and is on a rapid increase with the rise in number of cases, which enables rapid identification and isolation of infected individuals. The majority of this testing is PCR-based, detecting the presence of the SARS-CoV-2 virus only. Next-generation sequencing (NGS) and whole genome sequencing of the COVID-19 virus is providing metagenomics data of diagnostic test that is combined with clinical data to search for effective treatments.
Product & Service Segment Review
By product & service, the global metagenomics sequencing market is categorized into product & service type reagents & consumables, instruments, and services. The services segment is categorized in analysis & data interpretation solutions and metagenomics sequencing services. Reagents & consumables is anticipated to be the largest growing segment during the analysis period. Use of reagents & consumables ensures that the DNA utilized for metagenomics sequencing analysis is the representative of all cells present in the sample and ideal for generation of genomic libraries. In addition, the consumables used in pre-sequencing step ensure that the sample DNA that is subjected to sequencing is processed accurately to generate the desirable nucleotide sequence. There is an increase in the demand for metagenomics sequencing primarily due to rise in genetic disorders and increase in disease and metagenomics sequencing research projects which boosts the market growth.
By Product & Service
Services segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Technology Segment Review
By technology, the global metagenomics sequencing market is segmented into shotgun metagenomics sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and metatranscriptomics. The shotgun metagenomics sequencing segment is anticipated to be the largest growing segment during the analysis period, owing to the advantages offered by shotgun sequencing over other techniques of sequencing, and healthcare professionals, and the surge in number of metagenomics sequencing-based research activities. The rise in preference toward adoption of shotgun due to better advantages offered is anticipated to help the global metagenomics sequencing market gain traction. Since past few years, the usage of shotgun metagenomic sequencing has increased owing to the application where all the genomes in a DNA can be read with the help of shotgun metagenomic sequencing.
By Technology
16S rRNA Sequencing segment is projected as one of the most lucrative segment.
Application Segment Review
By application, the global metagenomics sequencing market is segmented into ecological & environmental metagenomics, clinical diagnostics, drug discovery, biofuel, industrial application. The drug discovery segment is anticipated to be the largest growing segment over the analysis period. Whereas, the clinical diagnostics segment is expected to register the highest growth rate from 2020 to 2028 owing to development of software packages and instruments utilized in the metagenomics studies. The rise in prevalence of pathogenic disease and viral disease have opened avenues for the growth of the global metagenomics sequencing market.
By Application
Drug Discovery segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Region segment review
North America is expected to maintain its dominance during the forecast period due to The three major countries of North America considered in the report include the U.S., Canada, and Mexico. North America is dominating the market of overall global metagenomics sequencing and expected to dominate throughout the forecast period. This is attributed to the increase in implementation of DNA sequencing across metagenomics applications in this region. In addition, rapid adoption of novel sequencing technologies in this region has contributed to its dominance. Increase in acquisition, product launch, and product approval by key players of this market operate in North America turn, fuels growth of the market.
By Region
North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.
Major players that operate in this metagenomics sequencing market include BGI Genomics Co., Ltd., Eurofins Genomics, Illumina, Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd, Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc., and Thermo Fisher Scientific Inc.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current global metagenomics sequencing market trends and forecast estimations from 2020 to 2028, which assists to identify the prevailing market opportunities.
- An in-depth metagenomics sequencing market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2028, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the global metagenomics sequencing market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global metagenomics sequencing market.
Key Market Segments
By Product & Service
- Reagents & Consumables
- Instruments
- Services
- Analysis & Data Interpretation Solutions
- Metagenomics Sequencing Services
By Technology
- Shotgun Metagenomics Sequencing
- 16S rRNA Sequencing
- Whole Genome Sequencing & De Novo Assembly
- Metatranscriptomics
By Application
- Ecological & Environmental Metagenomics
- Clinical Diagnostics
- Drug Discovery
- Biofuel
- Industrial Applications
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Metagenomics Sequencing Market Report Highlights
| Aspects | Details |
 By PRODUCT & SERVICE |
|
 By TECHNOLOGY |
|
 By APPLICATION |
|
 By Region |
|
 Key Market Players | QIAGEN N.V., PERKINELMER INC., .ILLUMINA, INC., SWIFT BIOSCIENCES INC., EUROFINS SCIENTIFIC SE (EUROFINS GENOMICS), .MACROGEN INC., BGI GENOMICS CO LTD, THERMO FISHER SCIENTIFIC, INC., OXFORD NANOPORE TECHNOLOGIES LTD., PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
Analyst Review
This section provides opinions of the top-level CXOs in the clinical area of the global metagenomics sequencing market. In accordance with several interviews conducted, the utilization of global metagenomics sequencing is expected to witness a significant growth in the forecast period due to increase in prevalence of genetic disorders, and rise in applications of metagenomics sequencing in clinical diagnostic and drug discovery. Increase in interest of healthcare providers and biofuel owing to several benefits offered by metagenomics sequencing is boosting the market. Metagenomics involves direct genetic analysis and it gives information about relative abundance of different organisms and the community structure. While the market is growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players.
According to the perspectives of CXOs, rise in advancements regarding DNA sequencing and surge in expansion of metagenomics applications drive the market growth. In addition, increase in metagenomics sequencing, advancements in medical technology leading to developments in metagenomics sequencing, significant applications of metagenomics in various fields, initiatives, and funding from government & private bodies for large-scale sequencing projects, and decline in cost of sequencing are the key factors that contribute toward the growth of the market worldwide. The major restraints of this market are ethical issues related to bone grafting and high cost of surgeries. Emerging markets are gaining more importance for majority of the manufacturers and distributors in the global metagenomics sequencing market. The need for improved healthcare services in emerging nations has resulted in a significant growth in shipment of these techniques, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. As per the CXOs, North America dominated the market in 2020, followed by Europe.
The total market value of global metagenomics sequencing Market is $974.3 million in 2020
The forecast period in the report is from 2021 to 2028
The market value of global metagenomics sequencing Market in 2020 was $974.3 Million
The base year for the report is 2020
Yes, global metagenomics sequencing companies are profiled in the report
The top companies that hold the market share in global metagenomics sequencing Market are BGI Genomics Co., Ltd., Eurofins Genomics, Illumina, Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd, Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc., and Thermo Fisher Scientific Inc.
The key trends in the global metagenomics sequencing Market are increase in drug discovery, clinical diagnostics and shotgun sequencing technique in research projects.
Loading Table Of Content...
